Stock Market

J&J ordered to pay $18.8 million in baby powder cancer claims, jury ruling (NYSE:JNJ)

Wachiwit/iStock editorial via Getty Images

8:35pm update: Added J&J commentary.

Johnson & Johnson (NYSE:JNJ) had to pay $18.8 million after a jury ruled in favor of a man who claimed the pharmaceutical company’s talc-based baby powder was responsible for his mesothelioma.

The jury awarded plaintiff Anthony Hernandez Valadez $18.8 million in damages in an Oakland, California courtroom on Tuesday.

Related Articles

Back to top button